African-American responses to the Human Genome Project

1999 ◽  
Vol 8 (3) ◽  
pp. 181-191 ◽  
Author(s):  
Fatimah Jackson

Data generated by the Human Genome Project are expected to have a powerful impact on how we view human biodiversity. Given the history of past biomedical and quasi-genetic abuse inflicted upon Americans of African descent, it is significant that African-Americans have been at the forefront of calls for a variation-inclusive Human Genome Project database and for full participation in all aspects of the project. As articulated in the 1994 Manifesto on Genomic Studies among African-Americans, historically and demographically representative genomic sampling is directly linked to the potential for social justice and equal access to the project's anticipated value. Now, as the Human Genome Project turns its attention to the collection and evaluation of human sequence variation, it is important to concurrently develop research strategies that foster inclusion and collaboration and produce benefits that are accessible to all who have paid for the project's success.

2021 ◽  
Vol 3 (1) ◽  
pp. 1-6
Author(s):  
Green RT ◽  
Nunlee-Bland G ◽  
Fluitt MB ◽  
Gambhir KK

Biological markers for Metabolic Syndrome, such as serum lipids and Hemoglobin A1c may have genetic variability among African Americans versus their Caucasian American counterparts. Although cases of Type 2 diabetes and its sequela significantly outweigh Caucasian Americans in the US, paradoxically research has found a lower prevalence of Metabolic Syndrome among blacks versus whites despite there being higher rates of Type 2 diabetes among the former population. Research has shown Metabolic Syndrome lipid parameters among African Americans are more favorable despite outstanding Type 2 diabetes incidence. With the emergence of the Human Genome Project and Genome Wide Association Studies, genetic differences in these parameters have been uncovered and genetic variability may play a role in such paradoxical mismatch. It may be reasonable to consider modifying Metabolic Syndrome parameters as given this new biological evidence. Hemoglobin A1c, also a biological marker used to monitor glucose levels over time, shows variability in its measurements with respect to African Americans. Genetic factors may play a role in the discrepancies among African Americans populations when using this parameter to monitor blood glucose. Precision medicine is now at the forefront of a biomedical new age, to find therapies that cater to specific populations based on genetic research. African Americans may not benefit from such a revolutionary paradigm shift in medicine due to evidence of lack of inclusivity in such studies like the Human Genome Project. Consideration should be made to the future of molecular medicine to include more minority populations such as African Americans in order to cater to specific differences rather than generalized standards of care.


Biomolecules ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 90
Author(s):  
Ryuji Hamamoto

The Human Genome Project, completed in 2003 by an international consortium, is considered one of the most important achievements for mankind in the 21st century [...]


Sign in / Sign up

Export Citation Format

Share Document